Pfizer Inc. (PFE)
28.89
+0.06
(+0.21%)
USD |
NYSE |
Nov 13, 16:00
29.08
+0.19
(+0.66%)
Pre-Market: 05:45
Pfizer Price to Book Value : 1.850 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.850 |
| November 12, 2026 | 1.846 |
| November 11, 2026 | 1.886 |
| November 10, 2026 | 1.880 |
| November 09, 2026 | 1.872 |
| November 06, 2026 | 1.882 |
| November 05, 2026 | 1.914 |
| November 04, 2026 | 1.972 |
| November 03, 2026 | 1.921 |
| November 02, 2026 | 1.964 |
| October 30, 2026 | 1.955 |
| October 29, 2026 | 1.918 |
| October 28, 2026 | 1.886 |
| October 27, 2026 | 1.908 |
| October 26, 2026 | 1.908 |
| October 23, 2026 | 1.923 |
| October 22, 2026 | 1.948 |
| October 21, 2026 | 1.912 |
| October 20, 2026 | 1.928 |
| October 19, 2026 | 1.886 |
| October 16, 2026 | 1.894 |
| October 15, 2026 | 1.886 |
| October 14, 2026 | 1.871 |
| October 13, 2026 | 1.817 |
| October 12, 2026 | 1.819 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.811 |
| October 08, 2026 | 1.782 |
| October 07, 2026 | 1.793 |
| October 06, 2026 | 1.761 |
| October 05, 2026 | 1.756 |
| October 02, 2026 | 1.780 |
| October 01, 2026 | 1.801 |
| September 30, 2026 | 1.826 |
| September 29, 2026 | 1.921 |
| September 28, 2026 | 1.921 |
| September 25, 2026 | 1.918 |
| September 24, 2026 | 1.901 |
| September 23, 2026 | 1.885 |
| September 22, 2026 | 1.868 |
| September 21, 2026 | 1.856 |
| September 18, 2026 | 1.850 |
| September 17, 2026 | 1.849 |
| September 16, 2026 | 1.837 |
| September 15, 2026 | 1.843 |
| September 14, 2026 | 1.854 |
| September 11, 2026 | 1.854 |
| September 10, 2026 | 1.850 |
| September 09, 2026 | 1.858 |
| September 08, 2026 | 1.859 |
| September 04, 2026 | 1.903 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.437 |
| Eli Lilly & Co. | 33.74 |
| Merck & Co., Inc. | 8.119 |
| Bristol Myers Squibb Co. | 5.540 |
| Viatris, Inc. | 1.744 |
Price to Book Value Related Metrics
| PE Ratio | 41.32 |
| PS Ratio | 2.596 |
| Price to Free Cash Flow | 14.01 |
| Price | 28.89 |
| Earnings Yield | 2.42% |
| Market Cap | 164.67B |
| Operating PE Ratio | 10.00 |
| Normalized PE Ratio | 12.73 |